Table of Contents Global Neurotherapeutic Drugs Market by Manufacturers, Regions, Type and Application, Forecast to 2023 1 Market Overview 1.1 Neurotherapeutic Drugs Introduction 1.2 Market Analysis by Type 1.2.1 Peripheral Nervous System Disorders (PNS) Disorder 1.2.2 Autonomous Nervous System (ANS) Disorder 1.2.3 Central Nervous System (CNS) Disorders 1.2.4 Other 1.3 Market Analysis by Applications 1.3.1 Hosptical 1.3.2 Drug Stores 1.3.3 Other 1.4 New Project SWOT Analysis of Neurotherapeutic Drugs 1.5 Industry News Analysis of Neurotherapeutic Drugs 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Neurotherapeutic Drugs 2.2 Raw Material Analysis of Neurotherapeutic Drugs 2.2.1 Raw Material A Market Analysis 2.2.2 Raw Material B Market Analysis 2.2.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Neurotherapeutic Drugs 2.4 Other Costs Analysis of Neurotherapeutic Drugs 2.5 Manufacturing Cost Structure Analysis of Neurotherapeutic Drugs 2.6 Manufacturing Process Analysis of Neurotherapeutic Drugs 2.7 Raw Materials Sources of Neurotherapeutic Drugs Major Manufacturers in 2017 2.8 Downstream Buyers of Neurotherapeutic Drugs 3 Global Neurotherapeutic Drugs Players Profiles and Sales Data 3.1 Abbott 3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.1.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.1.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.1.2.2 Autonomous Nervous System (ANS) Disorder 3.1.2.3 Central Nervous System (CNS) Disorders 3.1.3 Abbott Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Abbott Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Abbott Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.2 BD 3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.2.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.2.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.2.2.2 Autonomous Nervous System (ANS) Disorder 3.2.2.3 Central Nervous System (CNS) Disorders 3.2.3 BD Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 BD Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 BD Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.3 Novartis AG 3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.3.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.3.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.3.2.2 Autonomous Nervous System (ANS) Disorder 3.3.2.3 Central Nervous System (CNS) Disorders 3.3.3 Novartis AG Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Novartis AG Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Novartis AG Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.4 Johnson & Johnson 3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.4.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.4.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.4.2.2 Autonomous Nervous System (ANS) Disorder 3.4.2.3 Central Nervous System (CNS) Disorders 3.4.3 Johnson & Johnson Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Johnson & Johnson Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Johnson & Johnson Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.5 Pfizer 3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.5.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.5.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.5.2.2 Autonomous Nervous System (ANS) Disorder 3.5.2.3 Central Nervous System (CNS) Disorders 3.5.3 Pfizer Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Pfizer Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Pfizer Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.6 Sanofi-Aventis 3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.6.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.6.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.6.2.2 Autonomous Nervous System (ANS) Disorder 3.6.2.3 Central Nervous System (CNS) Disorders 3.6.3 Sanofi-Aventis Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Sanofi-Aventis Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Sanofi-Aventis Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.7 Biogen 3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.7.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.7.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.7.2.2 Autonomous Nervous System (ANS) Disorder 3.7.2.3 Central Nervous System (CNS) Disorders 3.7.3 Biogen Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Biogen Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Biogen Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.8 GlaxoSmithKline 3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.8.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.8.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.8.2.2 Autonomous Nervous System (ANS) Disorder 3.8.2.3 Central Nervous System (CNS) Disorders 3.8.3 GlaxoSmithKline Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 GlaxoSmithKline Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 GlaxoSmithKline Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.9 AstraZeneca 3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.9.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.9.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.9.2.2 Autonomous Nervous System (ANS) Disorder 3.9.2.3 Central Nervous System (CNS) Disorders 3.9.3 AstraZeneca Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 AstraZeneca Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 AstraZeneca Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.10 Merck 3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.10.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.10.2.1 Peripheral Nervous System Disorders (PNS) Disorder 3.10.2.2 Autonomous Nervous System (ANS) Disorder 3.10.2.3 Central Nervous System (CNS) Disorders 3.10.3 Merck Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Merck Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 Merck Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 4 Global Neurotherapeutic Drugs Market Competition by Manufacturers 4.1 Global Neurotherapeutic Drugs Sales and Share by Manufacturers (2012-2017) 4.2 Global Neurotherapeutic Drugs Revenue (Million USD) and Share (%) by Manufacturers (2012-2017) 4.3 Market Concentration Rate 4.3.1 Top 3 Neurotherapeutic Drugs Manufacturer Market Share 4.3.2 Top 6 Neurotherapeutic Drugs Manufacturer Market Share 4.4 Market Competition Trend 5 Global Neurotherapeutic Drugs Market Analysis by Regions 5.1 Global Neurotherapeutic Drugs Sales, Revenue and Market Share by Regions 5.1.1 Global Neurotherapeutic Drugs Sales by Regions (2012-2017) 5.1.2 Global Neurotherapeutic Drugs Revenue by Regions (2012-2017) 5.2 North America Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 5.3 Europe Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 5.4 Asia-Pacific Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 5.5 South America Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 5.6 Middle East and Africa Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 6 North America Neurotherapeutic Drugs by Countries 6.1 North America Neurotherapeutic Drugs Sales, Revenue and Market Share by Countries 6.1.1 North America Neurotherapeutic Drugs Sales by Countries (2012-2017) 6.1.2 North America Neurotherapeutic Drugs Revenue by Countries (2012-2017) 6.2 United States Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 6.3 Canada Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 6.4 Mexico Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 7 Europe Neurotherapeutic Drugs by Countries 7.1 North America Neurotherapeutic Drugs Sales, Revenue and Market Share by Countries 7.1.1 Europe Neurotherapeutic Drugs Sales by Countries (2012-2017) 7.1.2 Europe Neurotherapeutic Drugs Sales by Countries (2012-2017) 7.2 Germany Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 7.3 France Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 7.4 UK Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 7.5 Russia Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 7.6 Italy Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 8 Asia-Pacific Neurotherapeutic Drugs by Countries 8.1 Asia-Pacific Neurotherapeutic Drugs Sales, Revenue and Market Share by Countries 8.1.1 Asia-Pacific Neurotherapeutic Drugs Sales by Countries (2012-2017) 8.1.2 Asia-Pacific Neurotherapeutic Drugs Sales by Countries (2012-2017) 8.2 China Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 8.3 Japan Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 8.4 Korea Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 8.5 India Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 8.6 Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 9 South America Neurotherapeutic Drugs by Countries 9.1 South America Neurotherapeutic Drugs Sales, Revenue and Market Share by Countries 9.1.1 South America Neurotherapeutic Drugs Sales by Countries (2012-2017) 9.1.2 South America Neurotherapeutic Drugs Sales by Countries (2012-2017) 9.2 Brazil Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 9.3 Argentina Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 9.4 Columbia Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 10 Middle East and Africa Neurotherapeutic Drugs by Countries 10.1 Middle East and Africa Neurotherapeutic Drugs Sales, Revenue and Market Share by Countries 10.1.1 Middle East and Africa Neurotherapeutic Drugs Sales by Countries (2012-2017) 10.1.2 Middle East and Africa Neurotherapeutic Drugs Sales by Countries (2012-2017) 10.2 Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 10.3 UAE Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 10.4 Egypt Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 10.5 Nigeria Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 10.6 South Africa Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 11 Global Neurotherapeutic Drugs Market Segment by Type 11.1 Global Neurotherapeutic Drugs Sales, Revenue and Market Share by Type (2012-2017) 11.1.1 Global Neurotherapeutic Drugs Sales and Market Share by Type (2012-2017) 11.1.2 Global Neurotherapeutic Drugs Revenue and Market Share by Type (2012-2017) 11.2 Peripheral Nervous System Disorders (PNS) Disorder Sales Growth Rate and Price 11.2.1 Global Peripheral Nervous System Disorders (PNS) Disorder Sales Growth Rate (2012-2017) 11.2.2 Global Peripheral Nervous System Disorders (PNS) Disorder Price (2012-2017) 11.3 Autonomous Nervous System (ANS) Disorder Sales Growth Rate and Price 11.3.1 Global Autonomous Nervous System (ANS) Disorder Sales Growth Rate (2012-2017) 11.3.2 Global Autonomous Nervous System (ANS) Disorder Price (2012-2017) 11.4 Central Nervous System (CNS) Disorders Sales Growth Rate and Price 11.4.1 Global Central Nervous System (CNS) Disorders Sales Growth Rate (2012-2017) 11.4.2 Global Central Nervous System (CNS) Disorders Price (2012-2017) 11.5 Other Sales Growth Rate and Price 11.5.1 Global Other Sales Growth Rate (2012-2017) 11.5.2 Global Other Price (2012-2017) 11.6 Sales Growth Rate and Price 11.6.1 Global Sales Growth Rate (2012-2017) 11.6.2 Global Price (2012-2017) 12 Global Neurotherapeutic Drugs by Application 12.1 Global Neurotherapeutic Drugs Sales Market Share by Application (2012-2017) 12.2 Hosptical Sales Growth Rate (2012-2017) 12.3 Drug Stores Sales Growth Rate (2012-2017) 12.4 Other Sales Growth Rate (2012-2017) 12.5 Sales Growth Rate (2012-2017) 12.6 Sales Growth Rate (2012-2017) 13 Global Neurotherapeutic Drugs Market Forecast (2018-2023) 13.1 Global Neurotherapeutic Drugs Sales Volume, Revenue and Price Forecast (2018-2023) 13.1.1 Global Neurotherapeutic Drugs Sales Volume and Growth Rate Forecast (2018-2023) 13.1.2 Global Neurotherapeutic Drugs Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Global Neurotherapeutic Drugs Price and Trend Forecast (2018-2023) 13.2 Global Neurotherapeutic Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Global Neurotherapeutic Drugs Sales Volume and Growth Rate Forecast by Regions (2018-2023) 13.2.2 Global Neurotherapeutic Drugs Revenue and Growth Rate Forecast by Regions (2018-2023) 13.2.3 Global Neurotherapeutic Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Neurotherapeutic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 North America (United States, Canada and Mexico) Neurotherapeutic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 Europe (Germany, France, UK, Russia and Italy) Neurotherapeutic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neurotherapeutic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 South America (Brazil, Argentina, Columbia) Neurotherapeutic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neurotherapeutic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.3 Global Neurotherapeutic Drugs Sales Volume, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Global Neurotherapeutic Drugs Sales Forecast by Type (2018-2023) 13.3.2 Global Neurotherapeutic Drugs Revenue Forecast by Type (2018-2023) 13.3.3 Global Neurotherapeutic Drugs Price Forecast by Type (2018-2023) 13.4 Global Neurotherapeutic Drugs Sales Volume Forecast by Application (2018-2023) 13.4.1 Global Neurotherapeutic Drugs Sales Forecast by Application (2018-2023) 13.4.2 Global Neurotherapeutic Drugs Market Share Forecast by Application (2018-2023) 14 Sales Channel, Distributors, Traders and Dealers 14.1 Sales Channel 14.1.1 Direct Marketing 14.1.2 Indirect Marketing 14.1.3 Marketing Channel Future Trend 14.2 Distributors, Traders and Dealers 15 Research Findings and Conclusion 16 Appendix 16.1 Methodology/Research Approach 16.2 Analyst Introduction 16.3 Data Source

List of Tables and Figures Figure Neurotherapeutic Drugs Picture Table Product Specifications of Neurotherapeutic Drugs Figure Global Sales Market Share of Neurotherapeutic Drugs by Types in 2017 Table Neurotherapeutic Drugs Types for Major Manufacturers Figure Peripheral Nervous System Disorders (PNS) Disorder Picture Figure Autonomous Nervous System (ANS) Disorder Picture Figure Central Nervous System (CNS) Disorders Picture Figure Other Picture Figure Neurotherapeutic Drugs Sales Market Share by Applications in 2017 Figure Hosptical Picture Figure Drug Stores Picture Figure Other Picture Figure New Project SWOT Analysis of Neurotherapeutic Drugs Table Industry News List of Neurotherapeutic Drugs Figure Industry Chain Structure of Neurotherapeutic Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Neurotherapeutic Drugs in 2017 Figure Manufacturing Process Analysis of Neurotherapeutic Drugs Table Raw Materials Sources of Neurotherapeutic Drugs Major Manufacturers in 2017 Table Major Buyers of Neurotherapeutic Drugs Table Abbott Basic Information List Table Abbott Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Abbott Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Abbott Neurotherapeutic Drugs Sales Global Market Share (%) (2012-2017) Figure Abbott Neurotherapeutic Drugs Revenue Global Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Abbott Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Abbott Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Abbott Neurotherapeutic Drugs Volume in Other and Its Application Share Table BD Basic Information List Table BD Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure BD Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure BD Neurotherapeutic Drugs Sales Global Market Share (%) (2012-2017) Figure BD Neurotherapeutic Drugs Revenue Global Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table BD Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table BD Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table BD Neurotherapeutic Drugs Volume in Other and Its Application Share Table Novartis AG Basic Information List Table Novartis AG Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis AG Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Novartis AG Neurotherapeutic Drugs Sales Global Market Share (%) (2012-2017) Figure Novartis AG Neurotherapeutic Drugs Revenue Global Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novartis AG Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Novartis AG Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Novartis AG Neurotherapeutic Drugs Volume in Other and Its Application Share Table Johnson & Johnson Basic Information List Table Johnson & Johnson Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Johnson & Johnson Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Johnson & Johnson Neurotherapeutic Drugs Sales Global Market Share (%) (2012-2017) Figure Johnson & Johnson Neurotherapeutic Drugs Revenue Global Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Johnson & Johnson Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Johnson & Johnson Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Johnson & Johnson Neurotherapeutic Drugs Volume in Other and Its Application Share Table Pfizer Basic Information List Table Pfizer Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Pfizer Neurotherapeutic Drugs Sales Global Market Share (%) (2012-2017) Figure Pfizer Neurotherapeutic Drugs Revenue Global Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Pfizer Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Pfizer Neurotherapeutic Drugs Volume in Other and Its Application Share Table Sanofi-Aventis Basic Information List Table Sanofi-Aventis Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sanofi-Aventis Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Sanofi-Aventis Neurotherapeutic Drugs Sales Global Market Share (%) (2012-2017) Figure Sanofi-Aventis Neurotherapeutic Drugs Revenue Global Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sanofi-Aventis Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Sanofi-Aventis Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Sanofi-Aventis Neurotherapeutic Drugs Volume in Other and Its Application Share Table Biogen Basic Information List Table Biogen Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Biogen Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Biogen Neurotherapeutic Drugs Sales Global Market Share (%) (2012-2017) Figure Biogen Neurotherapeutic Drugs Revenue Global Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Biogen Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Biogen Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Biogen Neurotherapeutic Drugs Volume in Other and Its Application Share Table GlaxoSmithKline Basic Information List Table GlaxoSmithKline Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure GlaxoSmithKline Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure GlaxoSmithKline Neurotherapeutic Drugs Sales Global Market Share (%) (2012-2017) Figure GlaxoSmithKline Neurotherapeutic Drugs Revenue Global Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GlaxoSmithKline Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table GlaxoSmithKline Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table GlaxoSmithKline Neurotherapeutic Drugs Volume in Other and Its Application Share Table AstraZeneca Basic Information List Table AstraZeneca Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure AstraZeneca Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure AstraZeneca Neurotherapeutic Drugs Sales Global Market Share (%) (2012-2017) Figure AstraZeneca Neurotherapeutic Drugs Revenue Global Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table AstraZeneca Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table AstraZeneca Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table AstraZeneca Neurotherapeutic Drugs Volume in Other and Its Application Share Table Merck Basic Information List Table Merck Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Merck Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Merck Neurotherapeutic Drugs Sales Global Market Share (%) (2012-2017) Figure Merck Neurotherapeutic Drugs Revenue Global Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Merck Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Merck Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Merck Neurotherapeutic Drugs Volume in Other and Its Application Share Table Global Neurotherapeutic Drugs Sales by Manufacturer (2016-2017) Figure Global Neurotherapeutic Drugs Sales Market Share by Manufacturer in 2016 Figure Global Neurotherapeutic Drugs Sales Market Share by Manufacturer in 2017 Table Global Neurotherapeutic Drugs Revenue by Manufacturer (2016-2017) Figure Global Neurotherapeutic Drugs Revenue Market Share by Manufacturer in 2016 Figure Global Neurotherapeutic Drugs Revenue Market Share by Manufacturer in 2017 Figure Top 3 Neurotherapeutic Drugs Manufacturer (Revenue) Market Share in 2017 Figure Top 6 Neurotherapeutic Drugs Manufacturer (Revenue) Market Share in 2017 Figure Global Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure Global Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) Table Global Neurotherapeutic Drugs Sales by Regions (2012-2017) Table Global Neurotherapeutic Drugs Sales Market Share by Regions (2012-2017) Table Global Neurotherapeutic Drugs Revenue by Regions (2012-2017) Table Global Neurotherapeutic Drugs Revenue Market Share by Regions in 2012 Table Global Neurotherapeutic Drugs Revenue Market Share by Regions in 2017 Figure North America Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure Europe Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure Asia-Pacific Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure South America Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure Middle East and Africa Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure North America Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) Table North America Neurotherapeutic Drugs Sales by Countries (2012-2017) Table North America Neurotherapeutic Drugs Sales Market Share by Countries (2012-2017) Figure North America Neurotherapeutic Drugs Sales Market Share by Countries in 2012 Figure North America Neurotherapeutic Drugs Sales Market Share by Countries in 2017 Table North America Neurotherapeutic Drugs Revenue by Countries (2012-2017) Table North America Neurotherapeutic Drugs Revenue Market Share by Countries (2012-2017) Figure North America Neurotherapeutic Drugs Revenue Market Share by Countries in 2012 Figure North America Neurotherapeutic Drugs Revenue Market Share by Countries in 2017 Figure United States Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure Canada Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure Mexico Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure Europe Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) Table Europe Neurotherapeutic Drugs Sales by Countries (2012-2017) Table Europe Neurotherapeutic Drugs Sales Market Share by Countries (2012-2017) Table Europe Neurotherapeutic Drugs Revenue by Countries (2012-2017) Table Europe Neurotherapeutic Drugs Revenue Market Share by Countries in 2012 Table Europe Neurotherapeutic Drugs Revenue Market Share by Countries in 2017 Figure Germany Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure UK Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure France Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure Russia Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure Italy Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure Asia-Pacific Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) Table Asia-Pacific Neurotherapeutic Drugs Sales by Countries (2012-2017) Table Asia-Pacific Neurotherapeutic Drugs Sales Market Share by Countries (2012-2017) Table Asia-Pacific Neurotherapeutic Drugs Sales Market Share by Countries (2012-2017) Table Asia-Pacific Neurotherapeutic Drugs Revenue by Countries (2012-2017) Table Asia-Pacific Neurotherapeutic Drugs Revenue Market Share by Countries (2012-2017) Figure China Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure Japan Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure Korea Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure India Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure Southeast Asia Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure South America Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) Table South America Neurotherapeutic Drugs Sales by Countries (2012-2017) Table South America Neurotherapeutic Drugs Sales Market Share by Countries (2012-2017) Figure South America Neurotherapeutic Drugs Sales Market Share by Countries in 2017 Table South America Neurotherapeutic Drugs Revenue by Countries (2012-2017) Table South America Neurotherapeutic Drugs Revenue Market Share by Countries (2012-2017) Figure South America Neurotherapeutic Drugs Revenue Market Share by Countries in 2017 Figure Brazil Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure Argentina Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure Columbia Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure Middle East and Africa Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) Table Middle East and Africa Neurotherapeutic Drugs Sales by Countries (2012-2017) Table Middle East and Africa Neurotherapeutic Drugs Sales Market Share by Countries (2012-2017) Figure Middle East and Africa Neurotherapeutic Drugs Sales Market Share by Countries in 2017 Table Middle East and Africa Neurotherapeutic Drugs Revenue by Countries (2012-2017) Table Middle East and Africa Neurotherapeutic Drugs Revenue Market Share by Countries (2012-2017) Figure Middle East and Africa Neurotherapeutic Drugs Revenue Market Share by Countries in 2012 Figure Middle East and Africa Neurotherapeutic Drugs Revenue Market Share by Countries in 2017 Figure Saudi Arabia Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure UAE Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure Egypt Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure Nigeria Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Figure South Africa Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) Table Global Neurotherapeutic Drugs Sales by Type (2012-2017) Table Global Neurotherapeutic Drugs Sales Share by Type (2012-2017) Table Global Neurotherapeutic Drugs Revenue by Type (2012-2017) Table Global Neurotherapeutic Drugs Revenue Share by Type (2012-2017) Figure Global Peripheral Nervous System Disorders (PNS) Disorder Sales Growth Rate (2012-2017) Figure Global Peripheral Nervous System Disorders (PNS) Disorder Sales Price (2012-2018) Figure Global Peripheral Nervous System Disorders (PNS) Disorder Sales Growth Rate (2012-2017) Figure Global Autonomous Nervous System (ANS) Disorder Sales Price (2012-2018) Figure Global Central Nervous System (CNS) Disorders Sales Growth Rate (2012-2017) Figure Global Central Nervous System (CNS) Disorders Sales Price (2012-2018) Figure Global Other Sales Growth Rate (2012-2017) Figure Global Other Sales Growth Rate (2012-2018) Table Global Neurotherapeutic Drugs Sales by Application (2012-2017) Table Global Neurotherapeutic Drugs Sales Share by Application (2012-2017) Figure Global Hosptical Sales Growth Rate (2012-2017) Figure Global Drug Stores Sales Growth Rate (2012-2017) Figure Global Other Sales Growth Rate (2012-2019) Figure Global Neurotherapeutic Drugs Sales, Revenue and Growth Rate (2018-2023) Table Global Neurotherapeutic Drugs Sales Forecast by Regions (2018-2023) Table Global Neurotherapeutic Drugs Market Share Forecast by Regions (2018-2023) Figure North America Sales Neurotherapeutic Drugs Market Forecast (2018-2023) Figure Europe Sales Neurotherapeutic Drugs Market Forecast (2018-2023) Figure Asia-Pacific Sales Neurotherapeutic Drugs Market Forecast (2018-2023) Figure South America Sales Neurotherapeutic Drugs Market Forecast (2018-2023) Figure Middle East and Africa Sales Neurotherapeutic Drugs Market Forecast (2018-2023) Table Global Neurotherapeutic Drugs Sales Forecast by Type (2018-2023) Table Global Neurotherapeutic Drugs Market Share Forecast by Type (2018-2023) Table Global Neurotherapeutic Drugs Sales Forecast by Application (2018-2023) Table Global Neurotherapeutic Drugs Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

Abbott BD Novartis AG Johnson & Johnson Pfizer Sanofi-Aventis Biogen GlaxoSmithKline AstraZeneca Merck